ATE102217T1 - Synthetisches peptid fuer einen hiv-1 impfstoff. - Google Patents

Synthetisches peptid fuer einen hiv-1 impfstoff.

Info

Publication number
ATE102217T1
ATE102217T1 AT90906803T AT90906803T ATE102217T1 AT E102217 T1 ATE102217 T1 AT E102217T1 AT 90906803 T AT90906803 T AT 90906803T AT 90906803 T AT90906803 T AT 90906803T AT E102217 T1 ATE102217 T1 AT E102217T1
Authority
AT
Austria
Prior art keywords
hiv
synthetic peptide
vaccine
synthetic
gpkepfrdyvdrfyk
Prior art date
Application number
AT90906803T
Other languages
English (en)
Inventor
Dwo Yuan Charles Sia
Pele Chong
Michel Klein
Original Assignee
Connaught Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connaught Lab filed Critical Connaught Lab
Application granted granted Critical
Publication of ATE102217T1 publication Critical patent/ATE102217T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT90906803T 1989-05-03 1990-05-03 Synthetisches peptid fuer einen hiv-1 impfstoff. ATE102217T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898910145A GB8910145D0 (en) 1989-05-03 1989-05-03 Synthetic peptides for an hiv-1 vaccine
PCT/CA1990/000146 WO1990013564A1 (en) 1989-05-03 1990-05-03 Synthetic peptides for an hiv-1 vaccine

Publications (1)

Publication Number Publication Date
ATE102217T1 true ATE102217T1 (de) 1994-03-15

Family

ID=10656139

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90906803T ATE102217T1 (de) 1989-05-03 1990-05-03 Synthetisches peptid fuer einen hiv-1 impfstoff.

Country Status (9)

Country Link
EP (1) EP0470980B1 (de)
JP (1) JP2609764B2 (de)
AT (1) ATE102217T1 (de)
CA (1) CA2053921C (de)
DE (1) DE69007099T2 (de)
DK (1) DK0470980T3 (de)
ES (1) ES2062521T3 (de)
GB (1) GB8910145D0 (de)
WO (1) WO1990013564A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4039925A1 (de) * 1990-12-14 1992-06-17 Behringwerke Ag Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung
JPH0748276A (ja) * 1992-03-26 1995-02-21 Inmeru:Kk Ｈｉｖ感染症予防ワクチンおよびその製造法
GB9208218D0 (en) * 1992-04-14 1992-05-27 British Bio Technology Hybrid particles
CA2164818C (en) * 1993-06-09 2003-09-23 Charles D.Y. Sia Tandem synthetic hiv-1 peptides
US5693325A (en) * 1994-03-15 1997-12-02 Molecumetics, Ltd. Peptide vaccines and methods relating thereto
CN1651457B (zh) * 1994-10-20 2010-07-28 巴斯德研究所 Hiv-1 o组(或亚组)逆转录病毒抗原的核苷酸序列
FR2731225B1 (fr) * 1995-03-03 2003-10-31 Pasteur Institut Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique
FR2734281B1 (fr) * 1995-05-18 1997-07-25 Commissariat Energie Atomique Fragments d'acide nucleique derives du genome du virus vih-1, peptides correspondants et leurs applications en tant que reactifs d'evaluation du risque de transmission materno-foetale du vih-1
US5972339A (en) * 1997-11-13 1999-10-26 The General Hospital Corporation Method of eliciting anti-HIV-1 helper T cell responses
US7105164B1 (en) 1998-04-07 2006-09-12 Sanofi Pasteur Limited HIV-specific cytotoxic T-cell responses
US6395714B1 (en) 1999-02-24 2002-05-28 Aventis Pasteur Limited Expressing gp140 fragment of primary HIV-1 isolate
JP2007528838A (ja) * 2003-12-24 2007-10-18 ライデン ユニバーシティ メディカル センター 腫瘍特異的ワクチンとしての合成タンパク質
FR2882557A1 (fr) * 2005-02-25 2006-09-01 Centre Nat Rech Scient Epitopes de vih et composition pharmaceutique les contenant
GB0716494D0 (en) * 2007-08-23 2007-10-03 Isis Innovation HIV-2 antigenic peptides
CN113412275A (zh) * 2018-12-13 2021-09-17 莱比锡免疫治疗(美国)有限公司 用于癌症免疫疗法的基于迷路蛋白的肽及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930000189B1 (ko) * 1984-10-18 1993-01-11 앵스뛰띠 빠스뙤르 임파선증과 후천성 면역 결핍증 바이러스의 항원을 제조하는 방법 및 이 항원에 대한 항체의 생산 방법
WO1986006414A1 (en) * 1985-04-29 1986-11-06 Genetic Systems Corporation Synthetic antigens for the detection of aids-related disease
WO1987002775A1 (en) * 1985-10-24 1987-05-07 Southwest Foundation For Biomedical Research Synthetic peptides and use for diagnosis and vaccination for aids and arc
AU592258B2 (en) * 1986-12-30 1990-01-04 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins
ES2058259T5 (es) * 1987-03-25 2000-09-01 Genetic Systems Corp Antigenos sinteticos para la deteccion de enfermedad relacionada con sida causada por lav-2.
CA1339363C (en) * 1987-05-01 1997-08-26 Alan Ray Flesher Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use

Also Published As

Publication number Publication date
DE69007099D1 (de) 1994-04-07
JPH04502013A (ja) 1992-04-09
JP2609764B2 (ja) 1997-05-14
EP0470980A1 (de) 1992-02-19
EP0470980B1 (de) 1994-03-02
ES2062521T3 (es) 1994-12-16
WO1990013564A1 (en) 1990-11-15
GB8910145D0 (en) 1989-06-21
DK0470980T3 (da) 1994-03-28
CA2053921A1 (en) 1990-11-04
CA2053921C (en) 1999-07-20
DE69007099T2 (de) 1994-06-01

Similar Documents

Publication Publication Date Title
ATE102217T1 (de) Synthetisches peptid fuer einen hiv-1 impfstoff.
ES2077666T3 (es) Proteina de union a fibronectina y su preparacion.
CA2164818A1 (en) Tandem synthetic hiv-1 peptides
ES2076142T3 (es) Peptidos para el diagnostico de anticuerpos para htlv-iii, su preparacion y uso.
IL91007A0 (en) Synthetic vaccine against aids virus
DE69105608D1 (de) Nagellack enthaltend Glycerintriester.
DE69434181D1 (de) Therapeutische Peptid Derivate
ATE380822T1 (de) Funf-helix protein
ATE110743T1 (de) Antikoagulierende peptide.
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
ES2192620T3 (es) Polipeptido receptor de il-13.
DE3789413D1 (de) Lymphokin-ähnliche Peptide.
EP0695171A1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
DK164088D0 (da) Syntetiske peptidantigener til paavisning af hiv-1-infektion
RU94044322A (ru) Замещенные в кольце z-амино-1,2,3,4-тетрагидронафталины и 3-аминохроманы
DK0500800T3 (da) Antohæmostatiske Faktor VII-peptider
IT1249684B (it) Epitopi della proteina env del virus dell'epatite c.
AU2381402A (en) Small acid-soluble spore protein and uses thereof
ATE118016T1 (de) Peptid mit einer aktivität gegen metastasen.
ATE385805T1 (de) Neue peptide
EP0440207A3 (en) Expression of hiv1 and hiv2 polypeptides and use thereof
FI900075L (fi) Medvaexthormon bindande peptid.
ES2095899T3 (es) Peptidos de la proteina gag de vih, su preparacion y uso.
UA42741C2 (uk) Пептид маститної вакцини (варіанти), пептид складного антигенного представлення (варіанти), фармацевтична композиція (варіанти)
SE9000793L (sv) Sdk-peptider,foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande dem

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time